conditionStudied

URI: https://gptkb.org/prop/conditionStudied

93 triples

GPTKB property

diseaseStudied • studiedCondition

Subject	Object
gptkb:CALM_trial	gptkb:Crohn's_disease
gptkb:EORTC-NCIC_trial	gptkb:glioblastoma
gptkb:MOMENTUM_3_trial	advanced heart failure
gptkb:CANTOS_trial	atherosclerosis
gptkb:MINDACT_trial	gptkb:cancer
gptkb:Max_Essex	gptkb:HIV
gptkb:A_Study_of_Donanemab_(LY3002813)_in_Participants_With_Preclinical_Alzheimer’s_Disease_(TRAILBLAZER-ALZ_3)	Preclinical Alzheimer’s Disease
gptkb:SURMOUNT-2	obesity
gptkb:NCT04072952	Obesity
gptkb:PolyHeme_Phase_III_Clinical_Trial	traumatic hemorrhagic shock
gptkb:EPOC16_(SIBO)	Small Intestinal Bacterial Overgrowth
gptkb:S9346_(prostate_cancer_trial)	prostate cancer
gptkb:A_Study_of_Pembrolizumab_(MK-3475)_in_Combination_With_Axitinib_as_First-Line_Treatment_for_Locally_Advanced_or_Metastatic_Renal_Cell_Carcinoma_(MK-3475-426/KEYNOTE-426)	Renal Cell Carcinoma
gptkb:NCT04374877	gptkb:COVID-19
gptkb:SURMOUNT-2	gptkb:type_2_diabetes
gptkb:NCT02475681	gptkb:Non-Small_Cell_Lung_Cancer
gptkb:Rivaroxaban_Once_Daily_Oral_Direct_Factor_Xa_Inhibition_Compared_with_Vitamin_K_Antagonism_for_Prevention_of_Stroke_and_Embolism_Trial_in_Atrial_Fibrillation	gptkb:atrial_fibrillation
gptkb:Relating_Clinical_Outcomes_in_Multiple_Myeloma_to_Personal_Assessment_of_Genetic_Profile_Study	multiple myeloma
gptkb:RE-LY_trial	gptkb:atrial_fibrillation
gptkb:CDC-PD	gptkb:Parkinson's_disease